Braeburn Pharmaceuticals racks up $110 mln
Braeburn Pharmaceuticals, which provides treatment solutions for opioid addiction, has secured $110 million in financing. Wellington Capital Management led the round with participation from other investors that included Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, Rock Springs Capital and Apple Tree Partners.
11 January 2018•1 min read
